Download: Clinical Development of Tanibirumab, anti-KDR neutralizing fully human IgG


Download this presentation here >

The European Antibody Congress  brings together big pharma, big biotech, SME Biotech, academia, regulators and the wider service provider community to discuss the latest R&D and advances in the antibody space – across mAbs, ADCs, bispecifics, multispecifics, and protein scaffolds.

At the 2013 event, delegates were fortunate enough to hear from Dr Jin-San Yoo, President and CEO, PharmAbcine Inc,  who delivered the presentation ‘Clinical Development of Tanibirumab, anti-KDR neutralizing fully human IgG‘.

Download this presentation here >

If you’re interested in in learning more and engaging in discussion on mAbs, ADC’s, bispecifics and antibody biosimilars, you might want to check out the European Antibody Congress 2014 – preparations are in full swing! Make sure you’re networking with senior executives and opinion leaders across the antibody space.

Leave a Reply

Your email address will not be published. Required fields are marked *